Research Article

Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year

Table 6

Correlations between the evaluated parameters and the recurrence of macular edema within 12 months.

valueOR95% CI
LowerUpper

Baseline SCP0.9090.9880.8001.220
Baseline DCP0.8270.9680.7211.298
Baseline FAZ0.7535.2070.0001153583
Baseline PERIM0.9971.0050.1049.714
Baseline AI0.43735.5180.004285773
Baseline FD-3000.2821.1200.9111.378
SCP at 6 months0.4850.9140.7091.177
DCP at 6 months0.2020.8530.6681.089
FAZ at 6 months0.3020.0600.000312.648
PERIM at 6 months0.4240.5960.1672.123
AI at 6 months0.423774.7430.0000659.173 × 109
FD-300 at 6 months0.7170.9800.8801.092
SCP at 12 months0.2290.4830.6371.114
DCP at 12 months0.5001.1180.8081.548
FAZ at 12 months0.1490.0080.00000985.768
PERIM at 12 months0.0310.0600.0050.774
AI at 12 months0.0194.51 × 1012131.8521.543 × 1023
FD-300 at 12 months0.2270.8850.7091.103
Changes at 12 months
SCP0.9540.9420.1267.037
DCP0.2494.0890.37344.775
FAZ0.6660.5480.0368.370
PERIM0.9991.377 × 10800
AI0.3983.7310.17778.802
FD-3000.5432.6400.11660.261
BCVA0.7600.6900.0637.512
CRT0.7600.6900.0637.512

SCP, superficial retinal capillary plexus; DCP, deep retinal capillary plexus; FAZ, foveal avascular zone; PERIM, perimeter; AI, acircularity index; BCVA, best-corrected visual acuity; CRT, central retinal thickness. In binary logistic regression analyses, the PERIM and AI at 12 months were significantly associated with recurrence of macular edema. .